Alexander has led the financing and commercialization aspects of the project since 2014. He is a co-inventor of the company’s technology and both his PhD and post-doc work have dealt with the development and characterization of peptide based drugs. Alexander worked as a consultant within the pharmaceutical industry, before returning to the. University of Copenhagen to concentrate on founding Antag Therapeutics and develop our technology.